People

Roderick Beijersbergen

droiaventures.com

Roderick Beijersbergen is named Investment Advisory Board in Droia’s current public directory. The published professional background includes Group leader at the Netherlands Cancer Institute; Head of the NKI Robotics and Screening Center; Expert in large scale functional genomics; Pioneer of pooled screening technology; Co-founder of Qameleon Therapeutics. This is a manager-published affiliation; advisory-board membership and Droia Labs scientific roles are qualified separately from the investment team. Exact appointment dates and personal cash participation are not inferred.